BLK vs BX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BlackRock exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a very conservative debt-to-equity ratio of 0.24. However, the stock is trading at a massive premium, with a current price of $1023.65 far exceeding both the Graham Number ($535.18) and the growth-based Intrinsic Value ($247.24). While revenue growth remains robust at 23.4%, a concerning divergence is evident as earnings growth has plummeted by 31.7% YoY. The combination of bearish insider activity and a 0/100 technical trend offsets the bullish analyst consensus.
Blackstone exhibits a dichotomy between explosive growth and valuation concerns. While the Piotroski F-Score of 4/9 indicates stable financial health, the stock is trading at a significant premium to its Graham Number ($31.04) and slightly above its growth-based intrinsic value ($114.17). Exceptional revenue growth (50.60%) and a strong earnings beat track record are offset by an unsustainable dividend payout ratio of 121.19% and a bearish technical trend.
Compare Another Pair
Related Comparisons
BLK vs BX: Head-to-Head Comparison
This page compares BlackRock, Inc. (BLK) and Blackstone Inc. (BX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.